MARKET WIREReuters • 2h ago
Iran's IRGC Navy says two tankers 'exploded' after hitting mines in Hormuz - ReutersIran's IRGC Navy says two tankers 'exploded' after hitting mines in Hormuz Reuters
Why LFST Stock advanced +1.83% Today — RQD Quant Desk Flash
$13.64 +1.83% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot)
EXT / AFTER-HRS: $13.66
LifeStance Health Group Inc. (LFST) carries a Roarable Rating of D+ (Sell) with 57/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.
ROARABLE D+ • SELL / AVOID
Cap $5.21B
INTERACTIVE SCENARIO DECK:
EXT / AFTER-HRS: $13.66 (+0.14%)🧬 Cannibal Buyback (-0.68% YoY Shares)⚙️ Cash Engine: 10/20 (D) • 7.7% FCF Margin
Verify 90D Bucket Audit →📊 Historical Track Record: Scores of 57/100 (D+) historically posted market-perform odds over rolling 90-day windows (-0.2% avg 90D alpha vs SPY • 52.2% hit rate — wait for RQD ≥ 70 breakout).
Audit Bucket Track Record →RQD QUANT TACHOMETERSELL / AVOID • D+
2-of-3 JEV AI Jury Bearish Warning
Cash
SEC
Whale
Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer
5-PILLAR SNOWFLAKE RADARRw D · Rk B-
Each axis scored 0–20
12M PRICE TARGET CONE-0.4% Base Target
WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for LFST)Realized 20D OHLCV Swing Band: ±7.2%
Deterministic 5-Pillar Attribution (57/100 Composite)
🔍 WHY LFST SCORES 57/100 (D+) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
▲ #1 Bullish Driver: SEC 10-K Forensic Risk+18/20 pts (32% of score)
Altman Z-Score 4.84 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 8/9
▲ #2 Bullish Driver: Cash Engine Quality+10/20 pts (18% of score)
SEC XBRL FY 2025 (10-K): 7.7% FCF Margin ($110.0M FCF) & 52% Gross Margin
▼ #1 Drag / Risk Factor: Whale & Options Positioning9/20 pts (-11 pt drag)
Put hedging (50% put share) caps near-term gamma upside (-11 pts vs max)
📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current
Q1 (-3Q)Grade D$12.42-5.5% Next Q
49
Q2 (-2Q)Grade C-$11.74+10.1% Next Q
52
Q3 (-1Q)Grade C-$12.93+5.5% Next Q
54
CurrentGrade D+$13.64-0.2% Hist 90D α
57
Trajectory: D (49) → D+ (57)Full Audit →
⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)GIDEON ASHMERE // FORENSIC SHORT & KILL-SWITCH DOSSIER
⚔️ Adversarial Opposing Case: Why the LFST Bull Thesis Could Fail
Even with a 57/100 (D+) score, LFST faces multiple-compression risk if current valuation multiples re-rate toward historical sector medians or if hyperscaler/enterprise customer concentration slows in upcoming 10-Q filings.
⚠️ Forensic Kill-Switch #1
Company executives have done more routine share selling than personal cash buying lately.
⚠️ Forensic Kill-Switch #2
Sensitive to high interest rates and tighter Federal Reserve market liquidity.
⚠️ Forensic Kill-Switch #3
Technical & Forensic Kill-Switch: A daily close below the 50D SMA ($12.48) or 200D SMA ($9.34) invalidates the momentum regime and cuts Target Base ($13.58) toward Bear Floor ($10.59).
🎲 LIVE PREDICTION MARKET ODDS TIED TO $LFST• $2.4M Crowd Pool • Kalshi / Polymarket Composite
Contract: “LFST Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”
AUTOMATED RQD QUANT DESK MOVER BRIEFINGFull Market News Desk →
Why LFST Stock advanced +1.83% Today — RQD Quant Desk Flash
LifeStance Health Group Inc. (LFST) advanced +1.83% to $13.64, trading at 99% of its 52-week range ($4.77 – $13.76). Stretched risk/reward at current multiples (1% return on capital) under elevated 10-year interest-rate pressure.
- ▸Technical Tape: Trading at 99% of its 52-week range ($4.77 – $13.76) with RSI-14 at 64.8 (BULLISH MOMENTUM).
- ▸Volatility Profile: Historical 20-day realized swing band of ±7.2% around $13.64 (no active unusual options sweep snapshot on file).
- ▸Fundamental Anchor: Roarable D+ (Sell) backed by 52% gross margin and $110.0M annual free cash flow.
Live LFST Headlines & Catalysts
MARKET WIRECNBC • 4h ago
Here are 3 big things we're watching in the stock market in the week aheadThe market could use a few victories in the days ahead, which will be filled with more earnings, an election, and jobs data.
MARKET WIRECNBC • 4h ago
Democratic Rep. Stevens endorses Rogers over El-Sayed in Michigan Senate electionHaley Stevens had lost the Democratic nomination for Senate in Michigan to Abdul El-Sayed earlier this year.
RISK WATCHReuters • 5h ago
Israeli strikes kill eight people in Gaza - medics say - ReutersIsraeli strikes kill eight people in Gaza - medics say Reuters
MARKET WIREReuters • 6h ago
Russia's FSB says minor detained over park attack threat after US tip-off - ReutersRussia's FSB says minor detained over park attack threat after US tip-off Reuters
MARKET WIREReuters • 7h ago
Iran, Qatari mediators hold third day of talks to end US-Iran war - ReutersIran, Qatari mediators hold third day of talks to end US-Iran war Reuters
CATALYSTReuters • 8h ago
Qatar surges, bucking Gulf market slide on Iran war concerns - ReutersQatar surges, bucking Gulf market slide on Iran war concerns Reuters
MARKET WIREReuters • 8h ago
OPEC+ keeps December oil output targets steady ahead of tougher call for 2027 - ReutersOPEC+ keeps December oil output targets steady ahead of tougher call for 2027 Reuters
ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk
Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring LFST)
- ✓Walkthrough of LFST's RQD Radar, SEC cash-conversion gap & downside invalidation levels
- ✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
- ✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
LFST // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +80.18%📐 HORIZONTAL RANGE
2026-10-30O $13.64H $13.76L $13.27C $13.64VOL 2.30M
RES: $14.88SUP: $11.14SMA50: $12.48SMA200: $9.34
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK
LFST Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Share Count & Dilution Monitor (#25)
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
Reverse-DCF Expectations Hurdle (#30)
48.0%/yr Implied 5Y Growth
vs. +13.9% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
Ellis Vennor Setup Ledger (#33)
No active Ellis Vennor swing setup published on LFST today. View full Setup Ledger →
🦋 Documented & Second-Order Butterfly Connections
Open Graph →
No direct multi-tier Butterfly edges indexed yet for LFST. Explore sector supply chains on /butterfly.
AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for LFST today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK
📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (LFST)
Health Care Rank #249 of 1016
⚔️ OPCH vs LFST Full Matrix →
1. Head-to-Head Health Care Peer Comparison (LFST vs. OPCH, HIMS, CHE, AVAH)
Industry: Medical/Nursing Services (29 Tracked Issuers)Across 1016 tracked Health Care securities in the Roarable RQD universe, LifeStance Health Group Inc. (LFST) ranks #249 by composite RQD confidence (57/100, grade D+) and #165 by equity capitalization ($5.21B). Within this direct 5-issuer industry benchmark cohort, OPCH leads on earnings valuation at 23.0x trailing P/E, while CHE leads on capital efficiency and profitability with 23.4% ROIC and 32.5% gross margin. CHE currently holds the highest overall quantitative score in the immediate peer group at 84/100 (A-) compared with LFST at 57/100 (D+).
| Ticker / Company | Roarable Grade | RQD Score | Trailing P/E | Gross Margin | ROIC | 1D Change | Market Cap | Head-to-Head |
|---|---|---|---|---|---|---|---|---|
| LFST
ACTIVE
LifeStance Health Group Inc. | D+ | 57/100 | — | — | 1.2% | +1.83% | $5.21B | Benchmark Subject |
| OPCH Option Care Health Inc. | B | 75/100 | 23.0x | 19.3% | 11.9% | +1.79% | $4.77B | /opch-vs-lfst → |
| HIMS Hims & Hers Health Inc. | C | 63/100 | 53.9x | 73.8% | 8.4% | +1.19% | $6.92B | /hims-vs-lfst → |
| CHE Chemed Corp | A- | 84/100 | — | 32.5% | 23.4% | +1.61% | $7.08B | /che-vs-lfst → |
| AVAH Aveanna Healthcare Holdings Inc. | C | 65/100 | — | 33.3% | 15.7% | +1.53% | $2.89B | /avah-vs-lfst → |
2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)
SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001845257In its most recent audited fiscal period (FY2025, filed 2025-12-31), LifeStance Health Group Inc. (LFST) reported GAAP revenue of $1.42B (+13.9% vs. FY2024 revenue of $1.25B , and +34.9% cumulative change since FY2023) , GAAP net income of $9.7M, operating cash flow of $146.2M, and free cash flow of $110.0M (+28.4% YoY). On the balance sheet, LFST closed FY2025 with $2.20B in total assets against $265.9M in total debt (Altman Z-Score: 4.84, Piotroski F-Score: 8/9).
| Fiscal Period | Filing Date | Revenue | Net Income | Operating Cash Flow | Free Cash Flow | Total Assets | Total Debt |
|---|---|---|---|---|---|---|---|
| FY2025 (FY) | 2025-12-31 | $1.42B | $9.7M | $146.2M | $110.0M | $2.20B | $265.9M |
| FY2024 (FY) | 2024-12-31 | $1.25B | -$57.4M | $107.3M | $85.7M | $2.12B | $279.8M |
| FY2023 (FY) | 2023-12-31 | $1.06B | -$186.3M | -$16.9M | -$16.9M | — | — |
3. LFST Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)
✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLEDIs LFST stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
As of 2026-11-01, LifeStance Health Group Inc. (NASDAQ: LFST) is rated D+ (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 57/100 at a spot price of $13.64 (+1.83% 1D, market cap $5.21B). Pillar breakdown: Fundamental Cash Engine 10/20, Institutional 13F & Options Flow 9/20, Executive Insider Alignment 18/20, FRED Macro Regime Fit 10/20, and SEC Balance-Sheet Forensics 10/20. Across 1016 tracked Health Care issuers, LFST ranks #249 in composite RQD confidence.
How does LFST compare to OPCH and HIMS in the Health Care sector?
Within the Health Care sector (Medical/Nursing Services), LFST carries a Roarable D+ (57/100 RQD), trailing P/E of N/A, gross margin of —, and ROIC of 1.2%. By comparison, OPCH (Option Care Health Inc.) holds a B grade (75/100 RQD, P/E 23.0x, ROIC 11.9%, cap $4.77B) and HIMS (Hims & Hers Health Inc.) posts a C grade (63/100 RQD, P/E 53.9x, ROIC 8.4%, cap $6.92B). Among the 5-stock peer group, OPCH leads on earnings multiple (23.0x) while CHE leads on capital efficiency (23.4% ROIC).
What are the biggest fundamental strengths and SEC risk factors for LFST?
Per LFST's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001845257), LifeStance Health Group Inc. generated $1.42B in revenue (+13.9% YoY), $9.7M in net income, and $110.0M in free cash flow against $2.20B in total assets and $265.9M in total debt. Key quantitative strengths: Clean SEC annual filing review with no major hidden accounting time-bombs.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.
Where is LFST trading relative to its 50-day, 200-day, and 52-week technical levels?
LFST last traded at $13.64 (+1.83% on volume of 2,470,474 shares), positioning the stock +9.29% above its 50-day simple moving average ($12.48) and +46.04% above its 200-day simple moving average ($9.34). Across its 52-week range of $4.77 to $13.76, LFST sits at the 98.7% percentile with a 14-day RSI of 64.8 (BULLISH MOMENTUM) and an implied next-earnings move of ±7.2% ($12.66 to $14.62).
LFST Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDWhy is LFST stock moving today?
Why LFST Stock advanced +1.83% Today — RQD Quant Desk Flash. Stretched risk/reward at current multiples (1% return on capital) under elevated 10-year interest-rate pressure.